AI in Healthcare August 13, 2021
Dave Pearson

Researchers have used deep learning to assess three key biomarkers of existing breast cancers on routinely acquired histology slides. In the process, the team has advanced AI-based biomarker analysis for managing a range of cancers.

The breakthrough comes as part of an ongoing research project led by Google Health in collaboration with Naval Medical Center San Diego and the Henry M. Jackson Foundation for the Advancement of Military Medicine. It’s described in a study published Aug. 14 in Communications Medicine.

When scored together, the three critical biomarkers—estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (ER/PR/HER2)—point treating physicians along appropriate care pathways in pursuit of optimal outcomes.

Currently available AI-aided scoring systems work well but can require additional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends, VA / DoD
How HP sees the era of the AI PC | Alex Cho
Who Wins If The New Biden AI Export Rules Stand?
AI's role in stroke care at Orlando Health, 2 years in
WindRose Invests in CIVIE, an AI-Powered Radiology Solutions Provider
Arcadia Launches AI-Powered Precision Medicine Solution

Share This Article